Introduction {#S0001}
============

Tuberculosis is one of the main factors of vital statistic in the third world countries. Ninety percent of all tuberculosis patients live in third world countries ([@CIT0001]). In some regions like Saharan desert in Africa 1000 of 100,000 people are infected with tuberculosis and HIV co-infection, among which one out of three dies from HIV virus ([@CIT0002]). Recent, spread and rise in multi-drug resistant *M. tuberculosis (MTB)* isolate had worsened the matter. In addition, the worldwide development of transport and migration contributes to globalize these threats. Therefore, there is an urgent need to understand and estimate the incidence of tuberculosis in large and small biographical ranges ([@CIT0003]).

In this context, effective methods for accurate identification and typing is required. However, all the current typing markers suffer from significant drawbacks. For example DNA fingerprinting method based on IS6110 is a powerful tool to study molecular epidemiology of *MTB* isolates. But RFLP based on IS6110 typing is difficult and time consuming, and cannot be applied to *MTB* strains with low or no IS6110 banding patterns ([@CIT0004]).

Spoligotyping analyzes the Direct Repeat (DR) locus in the genome of *M. tuberculosis*, which is composed of a cluster of 36 *bp* repeat sequences interspersed with unique spacers of 35 to 41 *bp*. By using a reverse Southern blotting technique, the variability in the spacer sequences can be interrogated and recorded in a digital code ([@CIT0005]). Although this method provides digital typing data, it is only measuring variability in a single locus and does not generally provide sufficient discrimination for outbreak investigation ([@CIT0006]).

Another molecular technique for strain typing of *MTB* is based on Variable Number Tandem Repeats (VNTRs) of Mycobacterial Interspersed Repetitive Units (MIRUs). The repeated units are 52 to 77 nucleotides in length and the number of repeated units can be determined by the size of the entire locus. Previous studies demonstrated the importance of MIRU-VNTR method for tracking epidemiological key events such as transmission or relapse and provide non-ambiguous data which are highly portable between different laboratories ([@CIT0007]).

The purpose of this study was to compare the frequency of unknown genetic pattern of *MTB* isolates by using single technique of "MIRU-VNTR" versus the combined techniques of "MIRU-VNTR and Spoligotyping".

Materials and Methods {#S0002}
=====================

Design and setting {#S20003}
------------------

The study was conducted in Mycobacteriology Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran (2009).

Participants and sampling {#S20004}
-------------------------

Sixty *MTB* isolate along with their clinical files (30 sensitive and 30 multi-drug resistant *MTB* from Mycobacteriology bank in MRC) were used for this study.

Extraction DNA {#S20005}
--------------

DNA from *M. tuberculosis* isolates was extracted from growth on LJ slants by a well standized method. In brief, fifty *µl* of Lysozyme (Merck, Germany) was added to the mycobacterial suspension in 400 *µl* of water, followed by stirring and incubation at 37 °*C*. Ten *µl* with 10 *mg/ml* of proteinase K (Merck, Germany) was added to the sample, which was incubated for 10 *min* at 65°*C*, and then heated at 100°*C* for 30 *min*. One volume of phenol/ chloroform/ isoamyl-alcohol 25: 24: 1 was added to the supernatant, mixed by inversion and centrifuged at 12,000 *xg* for 10 *min*. The aqueous phase was transferred to other tubs, and the extraction procedure was repeated. A volume of chloroform/ isoamyl-alcohol 24: 1 was added and mixed by inversion followed by centrifugation for 10 *min* at 12,000 *xg*. One hundred *µl* of 5 *M* Nacl and two volumes of absolute ethanol were added to the supernatant. Samples were incubated for 60 *min* at −20°*C* and centrifuged for 15 *min* at 12,000 *xg*. The pellet was washed twice with 1 *ml* of 70% ethanol and re suspended in 200 *µl* of 0.1 x TE buffer (1 *mM* Tris- Hcl, 0.1 *mM* EDTA, Ph 8). Four *µl* of this sample was used for PCR ([@CIT0008]).

MIRU -- VNTR typing {#S20006}
-------------------

PCR was performed in 25 *µl* volume that contained 5 to 50 *ng* of DNA, 0.5 *µm* of specific primers ([Table 1](#T0001){ref-type="table"}) in the presence of 1.5 *m* MgCl~2~, 100 *µm* of each d NTP, 70 *m* PCR buffer and 1.25 *u* recombinant DNA polymerase (Cinagen Co. Iran) ([@CIT0009]). DNA was amplified by general PCR. All PCRs were initiated by a 10 *min* denaturizing step at 72 °*C*. The temperature cycles for different types of PCRs were as follow: 35 cycles of 1 *min* at 94 °*C*, annealing temperatures were used as follow: 61, 60, 64, 67, 65, 64, 61, 64, 58, 63, 62 and 64 for MIRU loci 2, 4, 10, 16, 20, 23, 24, 26, 27, 31, 39 and 40, respectively. Also the MIRU copy numbers in the 12 MIRU-VNTR loci are shown in [Table 2](#T0002){ref-type="table"}, ([@CIT0005]).

###### 

Primer sequence of the MIRU-VNTR loci and Spoligotyping in this study

  Locus of MIRU                Primer sequence (5^′^→3^′^)
  ---------------------------- -----------------------------
  **2**                        TGGACTTGCAGCAATGGACCAACT F
                               TACTCGGACGCCGGCTCAAAA' R
  **4**                        GCGCGAGAGCCCGAACTGC F
                               GCGCAGCAGAAACGTCAGC R
  **10**                       GTTCTTGACCAACTGCAGTCGTCC F
                               GCCACCTTGGTGATCAGCTACCT R
  **16**                       TCGGTGATCGGGTCCAGTCCAAGTA F
                               CCCGTCGTGCAGCCCTGGTAC R
  **20**                       TCGGAGAGATGCCCTTCGAGTTAG F
                               GGAGACCGCGACCAGGTACTTGTA R
  **23**                       CAGCGAAACGAACTGTGCTATCAC F
                               CGTGTCCGAGCAGAAAAGGGTAT R
  **24**                       CGACCAAGATGTGCAGGAATACAT F
                               GGGCGAGTTGAGCTCACAGAA R
  **26**                       CCCGCCTTCGAAACGTCGCT F
                               TGGACATAGGCGACCAGGCGAATA R
  **27**                       TCGAAAGCCTCTGCGTGCCAGTAA F
                               GCGATGTGAGCGTGCCACTCAA R
  **31**                       ACTGATTGGCTTCATACGGCTTTA F
                               GTGCCGACGTGGTCTTGAT R
  **39**                       CGCATCGACAAACTGGAGCCAAAC F
                               CGGAAACGTCTACGCCCCACACAT R
  **40**                       GGGTTGCTGGATGACAACGTGT F
                               GGGTGATCTCGGCGAAATCAGATA R
                               
  **Locus of Spoligotyping**   Primer sequence (5^′^→3^′^)
                               
  **DR** ~**a**~               Biotin- GGTTTTGGGTCTGACGAC
  **DRb**                      CCGAGAGGGGACGGAAAC

MIRU-VNTR: Mycobacterial Interspersed Repetitive Unit Variable Number Tandem Repeat

###### 

MIRU locus information for *M. tuberculosis* H37RV

  MIRU alias    Locus name          Location on H37RV genome   Expected length in H37RV   No. of repeat and size repeat   Size of repeat (*bp*)
  ------------- ------------------- -------------------------- -------------------------- ------------------------------- ---------------------------
  **MIRU 02**   H37RV0154-53 *bp*   154111                     508                        2 (53)                          ![](AJMB-2-145-ilf1.jpg)
  **MIRU 04**   H37RV0580-77 *bp*   580546                     353                        3(77)                           ![](AJMB-2-145-ilf2.jpg)
  **MIRU 10**   H37RV0959-53 *bp*   959868                     643                        3(53)                           ![](AJMB-2-145-ilf3.jpg)
  **MIRU16**    H37RV1644-53 *bp*   1644026                    671                        2(53)                           ![](AJMB-2-145-ilf4.jpg)
  **MIRU20**    H37RV2059-77 *bp*   2059429                    591                        2(77)                           ![](AJMB-2-145-ilf5.jpg)
  **MIRU23**    H37RV2531-53 *bp*   2531560                    873                        6(53)                           ![](AJMB-2-145-ilf6.jpg)
  **MIRU24**    H37RV2387-54 *bp*   2684427                    447                        1(52)                           ![](AJMB-2-145-ilf7.jpg)
  **MIRU26**    H37RV2996-51 *bp*   2996002                    614                        3(51)                           ![](AJMB-2-145-ilf8.jpg)
  **MIRU27**    H37RV3006-53 *bp*   3006875                    657                        3(53)                           ![](AJMB-2-145-ilf9.jpg)
  **MIRU31**    H37RV3192-53 *bp*   3192168                    651                        3(53)                           ![](AJMB-2-145-ilf10.jpg)
  **MIRU39**    H37RV4348-53 *bp*   4348401                    646                        2(53)                           ![](AJMB-2-145-ilf11.jpg)
  **MIRU40**    H37RV0802-54 *bp*   802194                     408                        1(54)                           ![](AJMB-2-145-ilf12.jpg)

MIRU-VNTR: Mycobacterial Interspersed Repetitive Unit Variable Number Tandem Repeat

Analysis {#S20007}
--------

Genetic analysis patterns MIRU-VNTR for each strain to a twenty digit profile from right to left indicate loci 2, 4, 10, 16, 20, 23, 24, 26, 27, 31, 39 and 40, respectively. For example pattern of genetic strains H37RV (*M. tuberculosis* standard strain) a 2, 3, 3, 2, 2, 6, 1, 3, 3, 3, 2 and 1 is the genetic pattern that can be seen in this model in [Figure 1A](#F0001){ref-type="fig"} ([@CIT0010]).

![A) PCR products of the various *M. tuberculosis* H37RV isolates with using primer that amplify 12 locus MIRU-VNTR. Lane M, 100-*bp* molecular marker. B) Genotypic of *M. tuberculosis* H37RV. Spoligotyping is from the MIRU-VNTR plus database MIRU-VNTR: Mycobacterial Interspersed Repetitive Units Variable Number Tandem Repeat](AJMB-2-145-g001){#F0001}

Spoligotyping {#S20008}
-------------

Spoligotyping was performed as previously described by Kamerbeek et al ([@CIT0011]). The DR region was amplified by PCR using primers derived from the DR sequence. Fifty *µl* of the following reaction mixture was used for the PCR: 10 *ng* of DNA, 20 *pmol* each of primers DR~a~ and DR~b~, each deoxynucleoside triphosphate at 200 *mM*, PCR buffer, and 0.5 *u* of taq polymerase (Cinagen Co. Iran). The mixture was heated for 2 *min* at 94 °*C* and subjected to 30 cycles of 30 *sec* at 94 °*C*, 30 *sec* at 55 °*C*, and 1 *min* at 72 °*C*. The amplified DNA was hybridized to a set of 43 immobilized oligo-nucleotides, each corresponding to one of the unique spacer DNA sequence within the DR locus.

The sequence of the oligonucleotides used is given in [Table 2](#T0002){ref-type="table"}. These oligonucleotides were covalently bound to a hybridization membrane for hybridization. Twenty *µl* of the amplified PCR product was diluted in 150 *µl* of 2 Saline -- Sodium Phosphate -- EDTA (SSPE), supplemented with 0.1% sodium dodecyl sulfate, and heat denatured. The diluted samples (130 *µl*) were pipetted in to the parallel channels in such a way that the channels of the miniblotter apparatus were perpendicular to the rows of oligonucleotides deposited previously. Hybridization was done for 60 *min* at 60 °*C*.

After hybridization, the membrane was washed as previously described. Detection of hybridizing DNA was done using a (chemilu-minescent ammersham ECL direct nucleotide acid) detection kit. The 4 digit binary result was converted in to a 15 digit octal designa-tion as previously described ([@CIT0012]).

Analysis {#S20009}
--------

These rational systems ([Figure 1B](#F0001){ref-type="fig"}) are based on the identification of the spoligotype pattern as a 43- digit binary number (taking a negative as 0 and positive as 1), which can be presented in a shorter format by converting to either octal or hexadecimal formats. For the octal system, the pattern is read in groups of 3, as 3 -- digit binary number can be read as a single digit octal number. In this way the binary series 000, 001, 010, 011, 100, 101, 110, 111 is read respectively as 0, 1, 2, 3, 4, 5, 6, 7. Following 14 groups of 3, the 43^rd^ spacer is read on its own, simply as 0 or 1 ([@CIT0013]).

MIRU-VNTR plus {#S20010}
--------------

The information was analysed by MIRU-VNTR plus website. MIRU-VNTR plus software compares and analyses the received information with the information bank in its own software.

Codes of ethics {#S20011}
---------------

This study was short term research project and information regarding each patient kept confidential. The study was approved by the medical board of NRITLD.

Statistical analysis {#S20012}
--------------------

The Hunter -- Gaston Discriminatory Index (HGDI) described by Hunter and Gaston (Hunter and Gaston, 2003) was used as a numerical index for MIRU-VNTR discriminatory power. HGDI was calculated by using the following formula: ([@CIT0014]) $$D = 1 - \frac{1}{N(N - 1)}\sum\limits_{j = 1}^{s}{x_{j}(x_{j} - 1)}$$

Where, *N* stands for the total number of strains in the typing scheme, *S* stands for the total number of different MIRU-VNTR patterns, and *xj* stands for the number of strains belonging to the Jth pattern.

P less than 0.05 was considered as significant. Statistical package SPSS ([@CIT0015]) was used for analysis of data. Chi square was used to determine possible difference by means of unknown *MTB* strains between the single and combined techniques.

Results {#S0013}
=======

As it shown in [Table 3](#T0003){ref-type="table"} 34% of susceptible strains could not identified by MIRU-VNTR, and the remaining 66% were identified as Haarlem family (17%), Dehli/ CAS (17%), NEW1 (14%), and LAM, Uganda and M.X families were 7%. Similarly, 44% drug resistant strains could not be identified by MIRU-VNTR technique. Using both "MIRU-VNTR and Spoligotyping" techniques together significantly reduced the percentage of unknown strains ([Table 3](#T0003){ref-type="table"}).

###### 

Frequency of sensitive and drug resistance strains of *MTB* by "MIRU-VNTR" assay versus "MIRU-VNTR and Spoligotyping" together

  Families                           MIRU-VNTR No. (%)   MIRU-VNTR+ Spoligotyping No. (%)
  ---------------------------------- ------------------- ----------------------------------
  **Sensitive strains**                                  
  ** Known**                         20 (67) Case        27 (90) Case
  ** Haarlem**                       5 (16) Case         7 (23) Case
  ** Dehli/CAS**                     5 (16) Case         8 (26) Case
  ** NEW1**                          4 (14) Case         6 (20) Case
  ** LAM**                           2 (7) Case          2 (7) Case
  ** Uganda1**                       2 (7) Case          2 (7) Case
  ** M.X**                           2 (7) Case          2 (7) Case
  ** Unknown**                       10 (33) Case        3 (10) Case
  **Multi-drug resistant strains**                       
  ** Known**                         17 (57) Case        24 (80) Case
  ** Haarlem**                       4 (14) Case         6 (20) Case
  ** Dehli/CAS**                     4 (14) Case         5 (16) Case
  ** LAM**                           3 (10) Case         4 (14) Case
  ** Uganda 1**                      2 (7) Case          2 (7) Case
  ** Cameron**                       1(3) Case           2 (7) Case
  ** Beijing**                       1 (3) Case          1(3) Case
  ** Ghana**                         0 (0) Case          1(3) Case
  ** Bovis**                         1 (3) Case          1(3) Case
  ** Caparie**                       1 (3) Case          1(3) Case
  ** M.X**                           0 (0) Case          1(3) Case
  ** Unknown**                       13 (43) Case        6(20) Case
  **All strains**                                        
  ** Known**                         37 (62) Case        51(85) Case
  ** Unknown**                       23 (38) Case        9(15) Case

MIRU-VNTR: Mycobacterial Interspersed Repetitive Units Variable Number Tandem Repeat

As shown in [Table 3](#T0003){ref-type="table"}, thirteen strains with unknown sample (by "MIRU-VNTR" technique) decreased to 6 strains by using "MIRU-VNTR and Spoligotyping" technique. On the other hand strains (samples specified) increased by using the two techniques; because of the setting of the family samples for some of the unknown strains ([Table 3](#T0003){ref-type="table"}).

Overall by using "MIRU-VNTR" technique, 38% of isolates could not be identified whereas by applying "MIRU-VNTR and Spoligotyping" together only 15% of the isolates remained unknown (p \< 0.05).

In [Table 4](#T0004){ref-type="table"}, the allelic differences for MIRU loci had accounted based on HGDI statistic formula; that is loci 20, 24 and 27 had lower allele difference (HGDI ≤0.3), loci 31, 39 and 40 were in middle (0.3 ≤HGDI ≤0.6) and loci 10, 16, 23 and 26 had the most allele difference among the locus MIRU (HGDI ≥0.6).

###### 

Allellic diversity of each MIRU-VNTR locus

  ----------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ---------- -------
  **Locus**   **1**   **2**   **3**   **4**   **5**   **6**   **7**   **8**   **9**   **HGDI**   
  **2**       **M**   1       60      --      --      --      --      --      --      --         0
              **S**   --      33      --      --      --      --      --      --      --         0
  **4**       **M**   --      61      --      --      --      --      --      --      --         0
              **S**   --      31      --      --      --      --      --      --      --         0
  **10**      **M**   1       18      14      11      13      4       --      --      --         70%
              **S**   --      16      5               8       3       1       --      --         66%
  **16**      **M**   4       16      32      8       1       --      --      --      --         64%
              **S**   2       2       18      10      1       --      --      --      --         59%
  **20**      **M**   2       59      --      --      --      --      --      --      --         10%
              **S**   3       30      --      --      --      --      --      --      --         14%
  **23**      **M**   --      --      --      --      6       55      --      --      --         16%
              **S**   --      --      --      1       --      32      --      --      --         10%
  **24**      **M**   61      --      --      --      --      --      --      --      --         0.02%
              **S**   33      --      --      --      --      --      --      --      --         0
  **26**      **M**   --      2       2       6       24      13      8       5       1          78%
              **S**   --      --      --      7       10      1       9       6       --         76%
  **27**      **M**   --      3       3       55      --      --      --      --      --         17%
              **S**   --      --      1       30      2       --      --      --      --         14%
  **31**      **M**           1       1       40      8       11      --      --      --         51%
              **S**   --      --      --      20      6       7       --      --      --         45%
  **39**      **M**   --      --      44      17      --      --      --      --      --         42%
              **S**   --      1       20      12      --      --      --      --      --         52%
  **40**      **M**   3       5       41      12      --      --      --      --      --         50%
              **S**   1       4       25      3       --      --      --      --      --         38%
  ----------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ---------- -------

MIRU-VNTR: Mycobacterial Interspersed Repetitive Units Variable Number Tandem Repeat; S strain (Susceptible), M strain (Resistant)

Based on [Table 4](#T0004){ref-type="table"} in both sensitive and resistant drug loci 10, 16 and 26 had the most allelic profile between the studied loci. Also loci 2, 4, 20 and 24 had the least allelic difference between all loci.

Discussion {#S0014}
==========

This study showed that "MIRU-VNTR" had low discriminatory power when it is used alone in comparison to when it is used together with Spoligotyping. Using both techniques together decreased the unknown genetic strains to about 10% in sensitive strains and 20% in drug resistant strains. Therefore, for epidemiological studies we suggest to use "MIRU-VNTR and Spoligotyping" techniques together.

DNA fingerprinting of *M. tuberculosis* isolates is useful for determining the extent of recent transmission in a community and the potential risk factors for recent transmission for identifying previously unsuspected transmission, monitoring the transmission of drug-resistant strains, and confirming laboratory cross contamination ([@CIT0016]).

In this study, based on MIRU-VNTR analysis the obtained genetic patterns of sensitive and resistance strains were as follows: 13.3% and 16.6% of them belonged to Haarlem, 10% and 16.6% of the second group belonged to Dehli/ CAS ([Figure 2A](#F0002){ref-type="fig"}). When both "MIRU-VNTR and Spoligotyping" techniques were used together, the patterns of Haarlem family reduced about 23% and Dehli/CAS was increased about 26% ([Figure 2B](#F0002){ref-type="fig"}). These strains are the most frequent patterns in Iranian population, as shown by Farnia et al in 2004 ([@CIT0017]).

![A) Genotypic and characteristic of resistance and sensitive strains. MIRU-VNTR are from the MIRU-VNTR plus database, MIRU-VNTR; Mycobacterial Interspersed Repetitive Units Variable Number Tandem Repeat; B) Genotypic and other characteristics of resistant and sensitivity strains. Spoligotyping and MIRU-VNTR from the MIRU-VNTR plus database, MIRU-VNTR; Mycobacterial Interspersed Repetitive Units Variable Number Tandem Repeat; RIF: Rifampicin, INH: Isoniazid](AJMB-2-145-g002){#F0002}

In another study by Dou et al in 2002, out of 356 isolates, 66 could not be identified by Spoligotyping, but when he applied both "MIRU-VNTR and Spoligotyping", the number reduced to 30 isolates ([@CIT0018]). In a study conducted by Goyal and co-workers (on 167 patients), Spoligotyping technique identified only genetic pattern of 67 strains but when they used RFLP and Spoligotyping together, the genetic patterns of 135 strains were identified ([@CIT0019]).

In this study the allele differences were accounted too. According to Sola et al loci 10, 16, 23, 26 and 40 were introduced as loci with the most allele polymorphism and loci 4, 20, 24 and 27 as the most poorly discriminated loci ([@CIT0020]). Another study conducted by Roring et al in 2002 demonstrated that by using another locus \[(VNTR) which their polymorphism is more\], we can identify genetic patterns of strains and their families more carefully. In a study by Romano et al, RFLP and Spoligotyping were used to determine the molecular epidemiology of the strains ([@CIT0021]). In the research performed by Skuce et al it was shown that techniques like MIRU-VNTR can be replaced by IS6110 in molecular epidemiology studies ([@CIT0022]).

Conclusion {#S0015}
==========

The results showed that in molecular epidemiologic studies of *MTB*, using the two techniques of "MIRU-VNTR and Spoligotyping" simultaneously could disseminate the genetic patterns of *MTB* strains in a much better manner as compared to using only "MIRU-VNTR" technique.

This study was supported by the Mycobacteriology Research Center of Shahid Beheshti University of Medical Sciences.
